Cimicifuga Comp. Dilution, 100 ml

Instructions for use for Cimicifuga Comp. Dilution, 100 ml

Important notes (compulsory information):

Cimicifuga Comp. Dilution. Applications: According to anthroposophical human and natural knowledge, the application areas include: complaints during menopause, especially with hot flashes, mood liability and circulatory disorders. Warning: Contains 28% by volume Alcohol!

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


LEAFLET: INFORMATION FOR THE USER

Cimicifuga Comp. Dilution

Dear patient, dear patient,
Please read the entire leaflet carefully before starting using this medicine, because it contains important information for you. This medicine is also available without medical prescription. In order to achieve the best possible treatment success, Cimicifuga Comp. however, be applied correctly.

• Lift the package leaflet. You might want to read it again.
• This medicine was prescribed personally and should therefore not be passed on to third parties.
• If you have further questions, please contact your doctor or pharmacist.

The leaflet includes:

1. What is Cimicifuga Comp. And what is it used for?
2. What do you need before taking Cimicifuga Comp. NOTE?
3. How is Cimicifuga Comp. To take?
4. WHAT SIDE EFFECTS ARE POSSIBLE?
5. WHAT ELSE IS IMPORTANT?

1. What is Cimicifuga Comp. And what is it used for?

Cimicifuga Comp. is an anthroposophical medicine during menopause.

Application areas:
According to anthroposophical human and natural knowledge, the application areas include: complaints during menopause, in particular with hot flashes, mood laboratory and circulatory disorders.

2. What do you need before taking Cimicifuga Comp. NOTE?

Cimicifuga Comp. It must not be used in known hypersensitivity to primroses.

Precautions for the application:
In case of faults or recurrence of the confluence as well as on continuing, unclear or new complaints, a doctor must be visited. Cimicifuga Comp. Only apply after consultation with your doctor.

Interactions with other medicines:
Not known.

Important information about certain ingredients of Cimicifuga Comp.:
This medicine contains 28 vol .-% alcohol.

3. How is Cimicifuga Comp. To take?

Take Cimicifuga Comp. always exactly after the instruction in this leaflet. Unless otherwise prescribed by the doctor, the usual dose: 1-3 times daily take 10-20 drops diluted with water before meals.

If you are taking Cimicifuga Comp. have forgotten:
Do not take the double dose if you forget the previous ingestion.

Please ask your doctor or pharmacist if you are not sure when using this medicine.

4. Which side effects are possible?

Side effects:
Not known.

Message of side effects:
If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not indicated in this leaflet. You can also effectively effect the Federal Institute for Medicines and Medical Devices, Dept. Pharmacovigilance, Kurt-Georg-Kiesinger Allee 3, D-53175 Bonn, website: www.bfarm.de. By reporting side effects, you can help to provide more information about the security of this medicine.

5. What else is important?

You may not use the medicinal product after the expiry date specified on the label and the folding box.

Composition:
10 g (= 10.4 ml) included: active ingredients: ethanol. Digetio (1: 3.1) From Onopordum Acanthium, Flos REC. producedprovided with 1% Hyoscyamus Niger, Herba REC. Ø (HAB, V. 2A) 0.05 g / ethanol. Digetio (1: 3.1) From Primula Veris, Flos REC. Made with 1% Hyoscyamus Niger, Herba REC. Ø (HAB, V. 2A) 0.05 g / Bryophyllum Dil. D1 1.25 G / Cimicifuga racemosa, ethanol. Decocert dil. D5 2.5 g / Leonurus Cardiaca 3B DIL. D2 2.5 g. Other ingredients: ethanol 96%, Ethanol 30% (m / m), purified water.

Dosage form and pack size:
100 ml dilution.

Pharmaceutical entrepreneur and manufacturer:
Weleda AG
Mailbox 1320
D-73503 Schwäbisch Gmünd
Tel.: 07171 / 919-414
Fax: 07171 / 919-200
E-mail: [email protected]

Status of information: July 2013.

Source: Information of the leaflet
Status: 01/2016